RIGL – rigel pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
12/10
09:13 am
rigl
Medium
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Cantor Fitzgerald from $15.00 to $25.00. They now have a "neutral" rating on the stock.
12/10
08:00 am
rigl
High
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
12/9
12:18 pm
rigl
Medium
Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition [Yahoo! Finance]
12/9
12:02 pm
rigl
Medium
Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition
12/6
01:06 pm
rigl
Low
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at B. Riley from $17.00 to $27.00. They now have a "neutral" rating on the stock.
11/7/2024
04:01 pm
RIGL
42.9%
BEAT
8/6/2024
04:01 pm
RIGL
5.8%
BEAT
5/7/2024
04:01 pm
RIGL
-16.6%
MISS
3/5/2024
04:01 pm
RIGL
5.4%
BEAT
12/10
08:49 am
Maintains
Neutral
Neutral
Cantor Fitzgerald
High
-10.2%
12/10
08:00 am
Reiterates
Buy
Buy
HC Wainwright
High
-15.2%
11/12
01:32 pm
Maintains
Buy
Buy
Citigroup
Low
-2.5%
11/12
01:32 pm
Maintains
Buy
Buy
Citigroup
Low
-2.5%
10/25
08:37 am
Reiterates
Buy
Buy
HC Wainwright
Low
-1.0%
12/9
04:16 pm
rigl
High
Form 8-K RIGEL PHARMACEUTICALS For: Dec 09
11/26
08:02 pm
rigl
Medium
Form 4 RIGEL PHARMACEUTICALS For: Nov 25 Filed by: RODRIGUEZ RAUL R
11/26
08:02 pm
rigl
Medium
Form 4 RIGEL PHARMACEUTICALS For: Nov 25 Filed by: Santos David A
11/26
08:02 pm
rigl
Medium
Form 4 RIGEL PHARMACEUTICALS For: Nov 25 Filed by: Schorno Dean L
11/14
05:18 pm
rigl
High
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC
Show more
Top News Gainers
1/13 Form 8-K RIGEL PHARMACEUTICALS For: Jan 13 20.0%
10/23 Here's Why Rigel Pharmaceuticals Stock Jumped as Much as 10.7% Today [The Motley Fool] 17.1%
4/27 Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update 9.0%
2/27 Rigel Pharmaceuticals, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] 6.5%
6/28 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.5%
3/4 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.4%
5/23 Form 4 RIGEL PHARMACEUTICALS For: May 22 Filed by: Schorno Dean L 5.9%
5/21 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.9%
9/23 Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia 5.1%
8/6 Q2/2019 6/30/2019 EPS -0.120 ZacksConsensus -0.140 ActVsEst 0.020 - Beat 4.6%
Top News Decliners
4/1 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.75 price target on the stock. -11.9%
11/6 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -9.9%
5/7 Form 8-K RIGEL PHARMACEUTICALS For: May 07 -7.4%
12/17 Rigel Announces Chief Commercial Officer Transition -6.4%
8/10 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $2.50 price target on the stock. -6.4%
4/30 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.8%
10/29 Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results -5.7%
5/1 Rigel Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders -5.5%
10/18 Rigel Pharma not quite there with European application for fostamatinib [Seeking Alpha] -4.9%
9/26 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $7.00 price target on the stock. -4.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3